Dare Bioscience Files 8-K: Director Changes & Officer Compensation Updates
Ticker: DARE · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1401914
| Field | Detail |
|---|---|
| Company | Dare Bioscience, INC. (DARE) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-compensation, director-changes
Related Tickers: DAR
TL;DR
Dare Bioscience 8-K: Director out, new director in, officer pay changes. Vote matters filed.
AI Summary
On July 9, 2025, Dare Bioscience, Inc. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of a new director, and updates to compensatory arrangements for certain officers. Additionally, the filing covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directorship and officer compensation can signal internal shifts or strategic realignments that may carry inherent business risks.
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- July 9, 2025 (date) — Filing date and earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors, only that these events occurred.
What specific changes were made to the compensatory arrangements of certain officers?
The filing indicates updates to compensatory arrangements but does not provide specific details on the nature or extent of these changes in the provided text.
What matters were submitted to a vote of security holders?
The filing confirms that matters were submitted to a vote of security holders, but the specific proposals are not detailed in this excerpt.
Are there any financial statements included with this 8-K filing?
Yes, the filing indicates that financial statements and exhibits are included as part of this 8-K report.
What is the SIC code for Dare Bioscience, Inc.?
The Standard Industrial Classification (SIC) code for Dare Bioscience, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Dare Bioscience, Inc. (DARE).